Beyond NEOD001 for systemic light-chain amyloidosis

Blood. 2018 Nov 1;132(18):1992-1993. doi: 10.1182/blood-2018-07-865857. Epub 2018 Sep 21.

Authors

Cindy Varga¹, Suzanne Lentzsch², Raymond L Comenzo¹

Affiliations

¹ The John Conant Davis Myeloma and Amyloid Program, Division of Hematology-Oncology, Department of Medicine, Tufts Medical Center, Boston, MA; and.
² Multiple Myeloma and Amyloidosis Service, Columbia University Medical Center, New York, NY.

PMID: 30242086
DOI: 10.1182/blood-2018-07-865857

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use*
Humans
Immunoglobulin Light-chain Amyloidosis / drug therapy*
Randomized Controlled Trials as Topic
Treatment Outcome

Substances

Antibodies, Monoclonal, Humanized
birtamimab